Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Investigation of lead concentrations in whole blood, plasma and urine as biomarkers for biological monitoring of lead exposure

Abstract

Lead in blood is a major concept in biomonitoring of exposure but investigations of its alternatives are scarce. The aim of the study was to describe different lead biomarkers’ variances, day-to-day and between individuals, estimating their fraction of the total variance. Repeated sampling of whole blood, plasma and urine were conducted for 48 lead-exposed men and 20 individuals under normal environmental lead exposure, in total 603 measurements. For lead workers, the fraction of the total variance attributed to differences between individuals was 91% for whole-blood lead (geometric mean 227 μg/l; geometric standard deviation (GSD): 1.55 μg/l); plasma 78% (0.57 μg/l; GSD: 1.84 μg/l); density-adjusted urine 82%; and unadjusted urine 75% (23.7 μg/l; GSD: 2.48 μg/l). For the individuals under normal lead exposure, the corresponding fractions were 95% of the total variance for whole blood (20.7 μg/l; GSD: 8.6 μg/l), 15% for plasma (0.09 μg/l; GSD: 0.04 μg/l), 87% for creatinine-adjusted urine and 34% for unadjusted (10.8 μg/l; GSD: 6.7 μg/l). Lead concentration in whole blood is the biomarker with the best ability to discriminate between individuals with different mean concentration. Urinary and plasma lead also performed acceptably in lead workers, but at low exposures plasma lead was too imprecise. Urinary adjustments appear not to increase the between-individual fraction of the total variance among lead workers but among those with normal lead exposure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Barbosa F, Tanus-Santos JE, Gerlach RF, Parsons PJ . A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect 2005; 113 (12): 1669–1674.

    Article  CAS  Google Scholar 

  2. Bergdahl IA, Skerfving S . Biomonitoring of lead exposure-alternatives to blood. J Toxicol Environ Health A. 2008; 71 (18): 1235–1243.

    Article  CAS  Google Scholar 

  3. Tsaih SW, Schwartz J, Lee ML, Amarasiriwardena C, Aro A, Sparrow D et al The independent contribution of bone and erythrocyte lead to urinary lead among middle-aged and elderly men: the normative aging study. Environ Health Perspect 1999; 107 (5): 391–396.

    Article  CAS  Google Scholar 

  4. Araki S, Aono H, Murata K . Adjustment of urinary concentration to urinary volume in relation to erythrocyte and plasma concentrations: an evaluation of urinary heavy metals and organic substances. Arch Environ Health 1986; 41 (3): 171–177.

    Article  CAS  Google Scholar 

  5. Araki S, Sata F, Murata K . Adjustment for urinary flow rate: an improved approach to biological monitoring. Int Arch Occup Environ Health 1990; 62 (6): 471–477.

    Article  CAS  Google Scholar 

  6. Sata F, Araki S . Adjustment of creatinine-adjusted value to urine flow rate in lead workers. Arch Environ Health 1996; 51 (4): 329–333 discussion 33-4.

    Article  CAS  Google Scholar 

  7. Bergdahl IA, Schutz A, Gerhardsson L, Jensen A, Skerfving S . Lead concentrations in human plasma, urine and whole blood. Scand J Work Environ Health 1997; 23 (5): 359–363.

    Article  CAS  Google Scholar 

  8. Smith D, Hernandez-Avila M, Tellez-Rojo MM, Mercado A, Hu H . The relationship between lead in plasma and whole blood in women. Environ Health Persp 2002; 110 (3): 263–268.

    Article  CAS  Google Scholar 

  9. European Food Safety Authority Panel on Contaminants in the Food Chain (CONTAM) . Scientific Opinion on Lead in Food. EFSA Journal 2010; 8: 1570–1716.

    Article  Google Scholar 

  10. Nordberg GF . Handbook on the Toxicology of Metals 3rd edn. Academic Press: Amsterdam, The Netherlands; Boston, MA, USA). 2007 pp xlvii p 975.

    Google Scholar 

  11. Lamadrid-Figueroa H, Tellez-Rojo MM, Hernandez-Cadena L, Mercado-Garcia A, Smith D, Solano-Gonzalez M et al Biological markers of fetal lead exposure at each stage of pregnancy. J Toxicol Environ Health A. 2006; 69 (19): 1781–1796.

    Article  CAS  Google Scholar 

  12. Bergdahl IA, Vahter M, Counter SA, Schutz A, Buchanan LH, Ortega F et al Lead in plasma and whole blood from lead-exposed children. Environ Res 1999; 80 (1): 25–33.

    Article  CAS  Google Scholar 

  13. Bergdahl IA, Gerhardsson L, Liljelind IE, Nilsson L, Skerfving S . Plasma-lead concentration: investigations into its usefulness for biological monitoring of occupational lead exposure. Am J Ind Med 2006; 49 (2): 93–101.

    Article  CAS  Google Scholar 

  14. Mazzachi BC, Peake MJ, Ehrhardt V . Reference range and method comparison studies for enzymatic and Jaffe creatinine assays in plasma and serum and early morning urine. Clin Lab 2000; 46 (1-2): 53–55.

    CAS  PubMed  Google Scholar 

  15. Barany E, Bergdahl IA, Schutz A, Skerfving S, Oskarsson A . Inductively coupled plasma mass spectrometry for direct multi-element analysis of diluted human blood and serum. J Anal Atom Spectrom 1997; 12 (9): 1005–1009.

    Article  CAS  Google Scholar 

  16. Rappaport SM, Kromhout H, Symanski E . Variation of exposure between workers in homogeneous exposure groups. Am Ind Hyg Assoc J. 1993; 54 (11): 654–662.

    Article  CAS  Google Scholar 

  17. Rappaport SM, Lyles RH, Kupper LL . An exposure-assessments strategy accounting for within- and between-worker sources of variability. Ann Occup Hyg 1995; 39 (4): 469–495.

    Article  CAS  Google Scholar 

  18. Bergdahl IA, Sheveleva M, Schutz A, Artamonova VG, Skerfving S . Plasma and blood lead in humans: capacity-limited binding to delta-aminolevulinic acid dehydratase and other lead-binding components. Toxicol Sci 1998; 46 (2): 247–253.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was funded by the European Union (Sixth Framework Programme; PHIME; FOOD-CT-2006-016253). The content reflects only the authors’ views; the European Union is not liable for any use that may be made of the information.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johan Nilsson Sommar.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sommar, J., Hedmer, M., Lundh, T. et al. Investigation of lead concentrations in whole blood, plasma and urine as biomarkers for biological monitoring of lead exposure. J Expo Sci Environ Epidemiol 24, 51–57 (2014). https://doi.org/10.1038/jes.2013.4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jes.2013.4

Keywords

This article is cited by

Search

Quick links